000028 國藥一致
按盤價 
20.190 +0.140 (+0.698%)
20.190 +0.140 (+0.698%) | 2026/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2025/12 人民幣(K¥) | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | ||
| 營業總收入 | 36,266,356 | -1.44% | 73,415,858 | 74,378,494 | 75,477,485 | 73,443,137 | |
| 減：營業總成本 | 35,498,297 | -1.27% | 71,812,830 | 73,017,475 | 73,277,097 | 71,309,688 | |
| 其中:營業成本 | 32,623,961 | -0.73% | 65,575,391 | 66,129,209 | 66,425,426 | 64,516,926 | |
| 財務費用 | 70,256 | -15.54% | 182,960 | 239,424 | 204,535 | 189,514 | |
| 資產減值損失 | (9,910) | 111.11% | (290,177) | (994,532) | (17,577) | (71,588) | |
| 公允價值變動收益 | (7,058) | -- | 3,129 | (20,675) | (15,161) | 28,871 | |
| 投資收益 | 96,852 | -28.85% | 217,607 | 241,793 | 237,029 | 139,131 | |
| 其中：對聯營企業和合營企業的投資收益 | 124,365 | -30.90% | 315,684 | 369,703 | 315,446 | 298,527 | |
| 營業利潤 | 834,430 | -9.94% | 1,512,829 | 573,478 | 2,467,425 | 2,306,069 | |
| 利潤總額 | 827,385 | -9.88% | 1,509,020 | 575,469 | 2,473,227 | 2,311,070 | |
| 減：所得稅費用 | 179,587 | -12.62% | 380,672 | 338,466 | 514,739 | 539,332 | |
| 淨利潤 | 647,798 | -9.09% | 1,128,349 | 237,004 | 1,958,487 | 1,771,738 | |
| 減：非控股權益 | 41,594 | -10.91% | (7,578) | (405,490) | 359,231 | 285,030 | |
| 股東淨利潤 | 606,204 | -8.97% | 1,135,927 | 642,493 | 1,599,256 | 1,486,708 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.990 | -9.17% | 2.040 | 1.150 | 2.870 | 2.670 | |
| 每股派息 (元) * | -- | -- | 0.616 | 0.366 | 0.680 | 0.800 | |
| 每股淨資產 (元) * | 30.828 | -5.40% | 33.437 | 31.747 | 31.290 | 37.666 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 04/09/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
